Analyst Ratings for Heat Biologics (HTBX)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/3/2021 | Cantor Fitzgerald | Kristen Kluska | New Coverage | Overweight (N/A) |
22.00 (N/A) |
8.19 (2.83) |
-65.45% | Details |
12/28/2020 | B.Riley » Updated 3/18/2022 |
Mayank Mamtani | New Coverage | Buy (N/A) |
8.00 (10.00) |
5.85 (2.83) |
-51.62% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |